Consistently, approximately half of T-ALL cases are associated with enhanced NOTCH signaling, and patient leukemic cells frequently bear somatic gain-of-function gene mutations in NOTCH1 and/or inactivating mutations of the NOTCH negative regulator FBXW7 [6,7]. Here, NOTCH1 is linked to acute lymphoblastic leukemia.